A brief literature review of low-level laser therapy for treating amyotrophic lateral sclerosis and confirmation of its effectiveness.

Article Synopsis

Title: A Brief Literature Review of Low-Level Laser Therapy for Treating Amyotrophic Lateral Sclerosis and Confirmation of its Effectiveness
Author: Sergey V. Moskvin (Scientific and Research Centre Matrix, Moscow, Russia)
Journal: BioMedicine (Taipei)
Publication Date: March 1, 2024; Volume 14, Issue 1, Pages 1–9
DOI: 10.37796/2211-8039.1430 PubMedPMC

Purpose & Methodology

The author aims to evaluate the potential of low-level laser therapy (LLLT), including intravenous laser blood illumination (ILBI), noninvasive laser blood illumination (NLBI), and local exposure methods, as promising treatments for amyotrophic lateral sclerosis (ALS). The review draws upon English and Russian literature sourced from databases such as PubMed, Scopus, Google Scholar, Web of Science, and the Russian Science Citation Index (RSCI) 研飞ivySCI+7PubMed+7lasmik.ru+7.

Key Findings

• Introduction: ALS is characterized by progressive degeneration of central and peripheral motor neurons, leading to loss of voluntary muscle function.

• LLLT Overview: LLLT is presented as a versatile and potentially effective therapeutic approach, particularly suited to neurodegenerative diseases jkslms.or.kr+11PubMed+11SciSpace+11.

• Evidence & Techniques: The review compiles studies supporting LLLT's utility for ALS, detailing specific application techniques including ILBI, NLBI, and local laser exposure methods that have been developed and employed in Russia PubMed.

• Conclusion: Based on both the literature and years of clinical experience in Russia, the author concludes that LLLT holds promise as a treatment modality for ALS, recommending further investigation and validationPMC+8PubMed+8ResearchGate+8.

Summary

In essence, the article offers a concise literature review, arguing in favor of low-level laser therapy as a potentially effective intervention in ALS treatment. It highlights different LLLT methodologies and underscores the need for more rigorous clinical validation.be happy to help!